Virtue Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $425K | Sell |
1,099
-118
| -10% | -$43.8K | 0.06% | 221 |
|
|
2026
Q1 | $347K | Buy |
1,217
+237
| +24% | +$77.9K | 0.05% | 238 |
|
|
2025
Q4 | $347K | Sell |
980
-9,134
| -90% | -$3.09M | 0.05% | 219 |
|
|
2025
Q3 | $1.2M | Buy |
10,114
+9,319
| +1,172% | +$2.9M | 0.19% | 84 |
|
|
2025
Q2 | $309K | Sell |
795
-277
| -26% | -$111K | 0.06% | 198 |
|
|
2025
Q1 | $468K | Buy |
1,072
+340
| +46% | +$136K | 0.05% | 270 |
|
|
2024
Q4 | $270K | Buy |
732
+119
| +19% | +$49.8K | 0.05% | 208 |
|
|
2024
Q3 | $319K | Sell |
613
-14
| -2% | -$7.48K | 0.06% | 193 |
|
|
2024
Q2 | $316K | Sell |
627
-120
| -16% | -$63.4K | 0.05% | 278 |
|
|
2024
Q1 | $373K | Buy |
747
+79
| +12% | +$39.3K | 0.07% | 257 |
|
|
2023
Q4 | $321K | Sell |
668
-383
| -36% | -$177K | 0.07% | 271 |
|
|
2023
Q3 | $466K | Hold |
1,051
| – | – | 0.08% | 230 |
|
|
2023
Q2 | $466K | Buy |
1,051
+407
| +63% | +$188K | 0.08% | 230 |
|
|
2023
Q1 | $291K | Sell |
644
-253
| -28% | -$120K | 0.05% | 313 |
|
|
2022
Q4 | $460K | Buy |
897
+228
| +34% | +$116K | 0.07% | 221 |
|
|
2022
Q3 | $304K | Sell |
669
-393
| -37% | -$188K | 0.05% | 177 |
|
|
2022
Q2 | $512K | Buy |
1,062
+22
| +2% | +$10.9K | 0.08% | 115 |
|
|
2022
Q1 | $511K | Sell |
1,040
-303
| -23% | -$139K | 0.08% | 264 |
|
|
2021
Q4 | $623K | Buy |
1,343
+257
| +24% | +$108K | 0.09% | 240 |
|
|
2021
Q3 | $405K | Sell |
1,086
-167
| -13% | -$63.5K | 0.07% | 273 |
|
|
2021
Q2 | $478K | Buy |
1,253
+75
| +6% | +$28.7K | 0.1% | 234 |
|
|
2021
Q1 | $423K | Buy |
1,178
+74
| +7% | +$23.8K | 0.1% | 225 |
|
|
2020
Q4 | $354K | Sell |
1,104
-187
| -14% | -$57.4K | 0.09% | 225 |
|
|
2020
Q3 | $347K | Sell |
1,291
-497
| -28% | -$134K | 0.09% | 214 |
|
|
2020
Q2 | $470K | Buy |
+1,788
| New | +$477K | 0.11% | 194 |
|
|
2020
Q1 | – | Sell |
-1,671
| Closed | -$505K | – | 82 |
|
|
2019
Q4 | $505K | Buy |
1,671
+245
| +17% | +$67.4K | 0.15% | 141 |
|
|
2019
Q3 | $342K | Buy |
1,426
+471
| +49% | +$129K | 0.11% | 182 |
|
|
2019
Q2 | $270K | Buy |
+955
| New | +$261K | 0.1% | 178 |
|
|
2018
Q4 | – | Sell |
-998
| Closed | -$274K | – | 129 |
|
|
2018
Q3 | $274K | Buy |
+998
| New | +$259K | 0.06% | 223 |
|
|
2018
Q2 | – | Sell |
-547
| Closed | -$124K | – | 268 |
|
|
2018
Q1 | $124K | Buy |
+547
| New | +$128K | 0.07% | 214 |
|
Other funds holding ELV
AACR
Virtue Capital Management's ELV Position: Q2 2026 in Review
Virtue Capital Management reduced its Elevance Health (ELV) stake by 9.7% in Q2 2026, selling an estimated $43.8K and leaving 1,099 shares worth $425K. The position accounts for 0.06% of the portfolio, ranked #221.
Virtue Capital Management first reported a position in ELV in Q1 2018 and has held it in 30 quarters since. The position peaked at $1.2M in Q3 2025. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Virtue Capital Management held 1,099 shares of Elevance Health worth $425K as of Q2 2026.
- Virtue Capital Management sold 118 Elevance Health shares in Q2 2026, an estimated $43.8K.
- Elevance Health made up 0.06% of Virtue Capital Management's portfolio in Q2 2026, its #221 holding.
- Virtue Capital Management first reported a position in Elevance Health in Q1 2018 and has held it in 30 quarters since.
- Virtue Capital Management's Elevance Health position peaked at $1.2M in Q3 2025.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.